U.S. unlikely to see another late-year omicron wave, but Fauci urges people to get new COVID booster
admin The U.S. is unlikely to suffer the same surge of COVID-19 infections this winter as…
Read MoreImmunizations
Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster…
Read MoreGlobal tally of COVID cases rises in reversal of recent trend, led by Japan, South Korea and the U.S.
The global tally of COVID-19 cases rose 2% in the week through Nov. 13 from…
Read MoreA robust booster campaign could prevent millions of missed school days among children ages 5 to 17, report finds
If 80% of children ages 5 and older get their COVID booster shots by the…
Read MoreNovavax stock rallies, even as company offers a dimmer sales forecast for vaccines
Novavax Inc. on Tuesday tweaked its full-year sales outlook to the low end of its…
Read MoreChina sees violent protests against COVID restrictions, and U.S. cases have been rising
Protests in northeastern China against the government’s zero-COVID policy became violent, as seven people were…
Read MoreHere’s how much China stocks still could rally from zero-COVID, say Goldman Sachs strategists
Wall Street stocks are poised for a bounce to start a new week, with politics…
Read MorePfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data…
Read MoreModerna stock falls after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion
Moderna Inc. shares moved lower Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter…
Read MoreWeekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from…
Read More